Document Detail


Treatment performance measures affect clinical outcomes in patients with acute systolic heart failure: report from the Korean Heart Failure Registry.
MedLine Citation:
PMID:  22343195     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: There is a paucity of data on the effects of adherence to treatment on outcomes for patients with acute heart failure (HF) in Korea. We used HF performance measures to evaluate overall adherence and whether this affects clinical outcomes.
METHODS AND RESULTS: Among 3,466 patients in the Korean Heart Failure Registry, 1,527 patients with left ventricular systolic dysfunction (LVSD) who survived hospitalization were evaluated. Modified validated performance measures were defined as follows: use at discharge of angiotensin-converting enzyme inhibitor (ACEI), angiotensin-receptor II blocker (ARB), β-blocker or aldosterone receptor antagonist. Adherence to performance measures were as follows: ACEI or ARB at discharge, 68.0%; β-blocker at discharge, 40.9%; aldosterone receptor antagonist at discharge, 37.5%. On multivariate analysis, adherence to the measure of ACEI or ARB use at discharge was significantly associated with mortality (odds ratio (OR), 0.344; 95% confidence interval (CI), 0.123-0.964), readmission (OR, 0.180; 95%CI, 0.062-0.522) and mortality/readmission (OR, 0.297; 95%CI, 0.125-0.707) at 60 days and that for β-blocker with mortality (OR, 0.337; 95%CI, 0.147-0.774) at 1 year.
CONCLUSIONS: For patients with LVSD in Korea, adherence to treatment performance measures, including prescription of an ACEI/ARB and β-blocker use at discharge, is associated with improved clinical outcomes.
Authors:
Young Jin Youn; Byung-Su Yoo; Jun-Won Lee; Jang-Young Kim; Seong Woo Han; Eun-Seok Jeon; Myeong-Chan Cho; Jae-Joong Kim; Seok-Min Kang; Shung Chull Chae; Byung-Hee Oh; Dong-Ju Choi; Myung Mook Lee; Kyu-Hyung Ryu;
Related Documents :
24408785 - Cost-effectiveness analysis of clinically indicated versus routine replacement of perip...
24433855 - Clinical practice, resource utilization, and outcomes of device closure of patent foram...
22937515 - Characteristics and clinical presentations of pediatric retinoblastoma in north-western...
24678075 - Comparison of preemptive analgesic effects of a single dose of nonopioid analgesics for...
23022235 - Would complex decongestive therapy reveal long term effect and lymphoscintigraphy predi...
9258465 - Analysis of trace elements in the hair of volunteers suffering from naso-pharyngeal can...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't     Date:  2012-02-17
Journal Detail:
Title:  Circulation journal : official journal of the Japanese Circulation Society     Volume:  76     ISSN:  1347-4820     ISO Abbreviation:  Circ. J.     Publication Date:  2012  
Date Detail:
Created Date:  2012-04-25     Completed Date:  2012-08-20     Revised Date:  2012-12-19    
Medline Journal Info:
Nlm Unique ID:  101137683     Medline TA:  Circ J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  1151-8     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Yonsei University Wonju Christian Hospital, Wonju, South Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adrenergic beta-Antagonists / therapeutic use
Advance Directive Adherence
Aged
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Disease-Free Survival
Female
Follow-Up Studies
Heart Failure, Systolic / mortality*,  therapy*
Humans
Male
Middle Aged
Registries*
Republic of Korea / epidemiology
Survival Rate
Task Performance and Analysis
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of achieved low-density lipoprotein cholesterol level with atorvastatin therapy on stabili...
Next Document:  Device closure of atrial septal defect: immediate and mid-term results.